Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 935-847-3 | CAS number: 1369773-39-6
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
AHU377 appeared to be a weak sensitizer with weak irritating potential in the murine LLNA TIER 1.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vivo (LLNA)
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 9-23 January 2008
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 429 (Skin Sensitisation: Local Lymph Node Assay)
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- mouse local lymph node assay (LLNA)
- Species:
- mouse
- Strain:
- Balb/c
- Sex:
- female
- Details on test animals and environmental conditions:
- Animal species and strain:
Mouse, Balb/c strain, inbred, SPF-Quality
Breeder/supplier:
Charles River France, L’Arbresle Cedex, France
Number of animals
30 females.
Age:
Approximately 8 weeks (at initiation of treatment).
Body weight range:
18 to 22 gram (at initiation of treatment).
Health Check:
A health inspection was performed prior to treatment, to ensure that the animals are in a good state of health. Special attention was paid to the ears, which were intact and free from any abnormality.
Animal quarters/husbandry
Location:
Specific Pathogen Free area: animal rooms no. 18 and 19.
Room temperature:
18.2 to 22.5° C.
Room relative humidity:
40 to 71%. Cleaning procedures in the room might have caused the temporary fluctuations above the optimal maximum level of 70% for relative humidity. Based on laboratory historical data, these fluctuations were considered not to have affected the study integrity.
Air changes:
Approximately 15 per hour.
Lighting cycle:
Fluorescent light for a 12-hour light/12-hour dark cycle.
Animal caging:
Group housing in Macrolon cages (MIII type; height 18 cm) containing sterilized sawdust as bedding material (Litalabo, S.P.P.S., Argenteuil, France). Animals were inadvertently individually housed in labeled Macrolon cages (MI type; height 12.5 cm) during the dosing period from Day 1 to Day 3.
The acclimatization period was at least 5 days before the start of treatment under laboratory conditions.
Cage enrichment:
Paper (Enviro-dri, Wm. Lillico & Son (Wonham Mill Ltd), Surrey, United Kingdom) was supplied as cage-enrichment during group housing.
Analysis of paper:
Results of analysis for each batch of paper did not reveal any findings that were considered to have affected the study integrity.
Food:
Free access to pelleted rodent diet (SM R/M-Z from SSNIFF® Spezialdiäten GmbH, Soest, Germany). Certificates of analysis were examined and then retained in the NOTOX archives.
Analysis of food:
Results of analysis for each batch of diet (nutrients and contaminants) were assessed and did not reveal any findings that were considered to have affected the study integrity.
Water:
Free access to tap-water.
Analysis of water:
Certificates of analysis were examined and archived. Analysis of water did not reveal any findings that were considered to have affected study integrity. - Vehicle:
- dimethylformamide
- Concentration:
- Test item concentrations selected for the main study were based on the results of a preliminary study.
In the main study, six Balb/c female mice per group received topical test and control items on the dorsum of both ears once a day on 3 consecutive days. Auricular lymph nodes were taken 24 hours after the last application. Endpoints: visual examination ears and sizes ear-draining lymph nodes, body weight at treatment start and day of necropsy, ear weight (skin irritation), ear-draining lymph node weights and cell counts (LN hyperplasia). Concentrations: vehicle control Dimethyl formamide, positive control DNCB (1-Chloro-2,4-Dinitrobenzene): 0.5% (w/w), and AHU377: 50%, 5%, 0.5% (w/w). - No. of animals per dose:
- 6
- Details on study design:
- Induction - Days 1, 2 and 3
For the experimental animals, the dorsal surface of both ears was epidermally treated (25 µl/ear) with the test item concentration, approximately the same time each day. The concentrations were mixed thoroughly using a vortex mixer immediately prior to dosing. The control animals were treated as described for the experimental animals, except that, instead of the test substance, the vehicle or positive control item was administered.
Weighing of ear punches and lymph nodes - Day 4
Approximately 24 hours after the last treatment, all animals were sacrificed by intra-peritoneal injection with pentobarbital (0.2 ml/animal Euthesate®; Sanofi Sante B.V., Maassluis, The Netherlands).
Both ears (left and right) were punched in the apical area using a biopsy punch (Stiefel, Ø 8 mm => 0.5 cm2). For each animal both punches were immediately weighed pooled per animal using an analytical balance after which the punches were discarded.
Both auricular draining lymph nodes (left and right) of mice were excised. The relative sizes of the nodes (as compared to normal) were estimated by visual examination and abnormalities of the nodes and surrounding area were recorded. For each animal both lymph nodes were pooled and immediately weight using an analytical balance.
Determination of total cell-counts of lymph nodes – Day 4
Following excision and weighing of the nodes, single cell suspensions of lymph node cells (LNC) were prepared in phosphate buffered saline (PBS) by gentle separation through stainless steel gauze (diameter 200 m mesh). LNC were collected in approximately 0.7 ml of PBS in a 24 wells plate that was kept on ice as much as possible.
Cell counts were determined using a Coulter Counter Z1 Dual (Beckman Coulter, The Netherlands). - Positive control substance(s):
- other: 1-CHLORO-2,4-DINITROBENZENE
- Statistics:
- Calculations were performed in MS EXCEL and statistical analysis was performed with GraphPad Prism 4 (Kruskal-Wallis test, followed by the Mann Whitney test).
- Positive control results:
- The positive control item DNCB elicited a reaction pattern with increased LN hyperplasia, which was in congruence with the expected mode of action of a contact allergen.
- Key result
- Parameter:
- SI
- Value:
- 1.03
- Test group / Remarks:
- 0.5% AHU377
- Key result
- Parameter:
- SI
- Value:
- 1.39
- Test group / Remarks:
- 5% AHU377
- Key result
- Parameter:
- SI
- Value:
- 2.07
- Test group / Remarks:
- 50% AHU377
- Parameter:
- other: Ear weight index
- Value:
- 0.92
- Test group / Remarks:
- 0.5% AHU377
- Parameter:
- other: Ear weight index
- Value:
- 0.98
- Test group / Remarks:
- 5% AHU377
- Parameter:
- other: Ear weight index
- Value:
- 1.49
- Test group / Remarks:
- 50% AHU377
- Parameter:
- other: LN weight index
- Value:
- 1.05
- Test group / Remarks:
- 0.5% AHU377
- Parameter:
- other: LN weight index
- Value:
- 1.22
- Test group / Remarks:
- 5% AHU377
- Parameter:
- other: LN weight index
- Value:
- 1.58
- Test group / Remarks:
- 50% AHU377
- Key result
- Parameter:
- other: Cell count index
- Value:
- 1.03
- Test group / Remarks:
- 0.5% AHU377
- Key result
- Parameter:
- other: Cell count index
- Value:
- 1.39
- Test group / Remarks:
- 5% AHU377
- Key result
- Parameter:
- other: Cell count index
- Value:
- 2.07
- Test group / Remarks:
- 50% AHU377
- Cellular proliferation data / Observations:
- No irritation of the ears was noted after visual examination in the majority of animals, except for the very slight irritation on one ear of one animal treated at 50%. Visual examination of the nodes revealed that all the nodes of the experimental and positive control animals were enlarged when compared to the vehicle control group. No macroscopic abnormalities of the surrounding areas were noted in any of the animals.
Statistically significant body weight loss was noted in the 0.5% group in comparison to the vehicle control. There were no clinical observations attributable to treatment with AHU377.
The positive control item DNCB elicited a reaction pattern with increased LN hyperplasia, which was in congruence with the expected mode of action of a contact allergen.
AHU377 did show a statistically significant decrease in ear weight at 0.5% and a statistically significant increase at 50% concentration.
AHU377 did cause dose related increases in LN weights and cell counts when compared to the vehicle control. - Interpretation of results:
- GHS criteria not met
- Conclusions:
- In conclusion, AHU377 appeared to be a weak sensitizer with weak irritating potential in the murine LLNA TIER 1. However the criteria for classification are not met as a 3 fold increase in cell proliferation was not observed at any of the doses tested in the LLNA assay.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed (not sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
When tested in the local lymph node assay, the maximum Stimulation Index when exposed to 50% w/w in DMF was 2.08. As an EC3 was not established, the substance is not classified for skin sensitisation according to 1272/2008/EC.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.